InvestorsHub Logo
Followers 31
Posts 2649
Boards Moderated 0
Alias Born 10/28/2013

Re: None

Thursday, 07/05/2018 11:07:59 AM

Thursday, July 05, 2018 11:07:59 AM

Post# of 462426
Re. enrollment. 2-73 had a big fan in that MD in charge of the clinic where they ran their studies. If he is still a fan, I would think he would be great help in speeding enrollment. As I recall, he was the top Psychiatrist in Australia for Alzheimer's. I don't remember reading in the PR whether they are going to only enroll genetic and otherwise identified suspected super-responders, but if so, that, of course would make enrollment more difficult. But again, they likely have the heaviest hitter in Australia assisting them in finding patients and talking clinics into participating.

US P3? Might want a partner. Could it be Biogen? As a cheerleader and long investor I believe it could be.

Makes total sense to do a study in Australia whether or not they do one in the US. And the study in Australia would be easier to setup and get approved, so would be announced first.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News